Sanofi has nearly completed its preparations for Britain’s planned exit from the European Union and is confident its additional stockpiling of medicines and other measures will prevent shortages for patients in the country. Read More

By Ian Dei

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.